Tapewire

Nasdaq · USD

ZVRA

ZEVRA THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
5212
SEC CIK
0001434647
Parsed reports
261

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202604
Feb 202604
Mar 202600
Apr 202600
May 202601
Jun 202601
Jul 202600
Aug 202602
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 12, 2026 Filed Oct 13, 2026 20:24 UTC
McFarlane Neil F.Director · President and CEO
SaleCommon Stock 20,000 $11.25 $224,948.00
Disclosure

SEC source: 0001434647-26-000075 · wk-form4_1791923065.xml · nonDerivative · entry 2

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 417,225

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 03-25-2026

F3 · price: This transaction was executed in multiple trades at prices ranging from $11.07 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 10, 2026 Filed Oct 13, 2026 20:24 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 50,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001434647-26-000075 · wk-form4_1791923065.xml · derivative · entry 3

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: 25% of the RSUs vested and settled on each of October 10, 2024, October 10, 2025 and October 10, 2026. The remaining 25% of the shares will vest on 10/10/2027, provided that at the relevant vesting date the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason.

F4 · derivative.expiration_date: 25% of the RSUs vested and settled on each of October 10, 2024, October 10, 2025 and October 10, 2026. The remaining 25% of the shares will vest on 10/10/2027, provided that at the relevant vesting date the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason.

Read SEC document
October 10, 2026 Filed Oct 13, 2026 20:24 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionCommon Stock 50,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001434647-26-000075 · wk-form4_1791923065.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 437,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
August 14, 2026 Filed Aug 17, 2026 20:32 UTC
Thompson RahsaanChief Legal & Compliance
SaleCommon Stock 42,666 $11.13 $474,774.45
Disclosure

SEC source: 0001434647-26-000073 · wk-form4_1786998758.xml · nonDerivative · entry 1

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,569

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 05-15-2026

F2 · price: This transaction was executed in multiple trades at prices ranging from $10.86 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 20:16 UTC Exercise / conversionStock Option (right to buy) · Derivative 12,300 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0001434647-26-000070 · wk-form4_1786565760.xml · derivative · entry 3

Watton Corey Michael · CIK 0001975404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,500

Underlying: Common Stock · 12,300 shares

Expires 2033-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares underlying this option, which was granted on May 3, 2023, were fully vested.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 20:16 UTC SaleCommon Stock 12,300 $11.25 $138,377.46
Disclosure

SEC source: 0001434647-26-000070 · wk-form4_1786565760.xml · nonDerivative · entry 2

Watton Corey Michael · CIK 0001975404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

F1 · price: This transaction was executed in multiple trades at prices ranging from $11.23 to $11.31. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 20:16 UTC Exercise / conversionCommon Stock 12,300 $4.97 $61,131.00
Disclosure

SEC source: 0001434647-26-000070 · wk-form4_1786565760.xml · nonDerivative · entry 1

Watton Corey Michael · CIK 0001975404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 22, 2026 Filed Jun 23, 2026 20:16 UTC
Thompson RahsaanChief Legal & Compliance
SaleCommon Stock 34,557 $12.68 $438,303.71
Disclosure

SEC source: 0001434647-26-000057 · wk-form4_1782245786.xml · nonDerivative · entry 2

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,235

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 01-08-2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $12.53 to $13.19. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 21, 2026 Filed Jun 23, 2026 20:16 UTC
Thompson RahsaanChief Legal & Compliance
Exercise / conversionRestricted Stock Unit · Derivative 66,667 $0.00 $0.00
Disclosure

SEC source: 0001434647-26-000057 · wk-form4_1782245786.xml · derivative · entry 3

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,667

Underlying: Common Stock · 66,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The first and second tranches of the restricted stock units vested and settled on June 21, 2025 and June 21, 2026, respectively, and the remaining tranche of the restricted stock units will vest and settle on the next anniversary thereafter, subject to the Reporting person's continued service through such vesting date.

F4 · derivative.expiration_date: The first and second tranches of the restricted stock units vested and settled on June 21, 2025 and June 21, 2026, respectively, and the remaining tranche of the restricted stock units will vest and settle on the next anniversary thereafter, subject to the Reporting person's continued service through such vesting date.

Read SEC document
June 21, 2026 Filed Jun 23, 2026 20:16 UTC
Thompson RahsaanChief Legal & Compliance
Exercise / conversionCommon Stock 66,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001434647-26-000057 · wk-form4_1782245786.xml · nonDerivative · entry 1

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,792

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
June 04, 2026 Filed Jun 18, 2026 20:16 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $11.17 $0.00
Disclosure

SEC source: 0001434647-26-000053 · wk-form4_1781813758.xml · derivative · entry 1

Watton Corey Michael · CIK 0001975404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-03

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
June 04, 2026 Filed Jun 18, 2026 20:16 UTC
Secor AliciaDirector
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $11.17 $0.00
Disclosure

SEC source: 0001434647-26-000054 · wk-form4_1781813773.xml · derivative · entry 1

Secor Alicia · CIK 0001584516 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-03

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
June 04, 2026 Filed Jun 18, 2026 20:16 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $11.17 $0.00
Disclosure

SEC source: 0001434647-26-000055 · wk-form4_1781813796.xml · derivative · entry 1

FAVORITO TAMARA A · CIK 0001288232 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-03

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
June 04, 2026 Filed Jun 18, 2026 20:15 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $11.17 $0.00
Disclosure

SEC source: 0001434647-26-000052 · wk-form4_1781813748.xml · derivative · entry 1

Calder Douglas W · CIK 0001510445 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-03

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
June 04, 2026 Filed Jun 18, 2026 20:15 UTC GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $11.17 $0.00
Disclosure

SEC source: 0001434647-26-000051 · wk-form4_1781813735.xml · derivative · entry 1

Anderson Thomas · CIK 0001612903 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-03

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
June 04, 2026 Filed Jun 18, 2026 20:15 UTC
Shih AlvinDirector
GrantStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $11.17 $0.00
Disclosure

SEC source: 0001434647-26-000050 · wk-form4_1781813721.xml · derivative · entry 1

Shih Alvin · CIK 0001610064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-03

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 4, 2026.

F2 · shares: This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.

Read SEC document
May 28, 2026 Filed May 29, 2026 20:16 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
GrantRestricted Stock Unit · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001434647-26-000037 · wk-form4_1780085770.xml · derivative · entry 2

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

Read SEC document
May 28, 2026 Filed May 29, 2026 20:16 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
GrantStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $11.40 $0.00
Disclosure

SEC source: 0001434647-26-000037 · wk-form4_1780085770.xml · derivative · entry 1

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2036-05-27

F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on March 1, 2027, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:32 UTC
Thompson RahsaanChief Legal & Compliance
SaleCommon Stock 1,794 $11.30 $20,272.20
Disclosure

SEC source: 0001434647-26-000034 · wk-form4_1778704324.xml · nonDerivative · entry 1

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,125

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 01-08-2026

Read SEC document
March 24, 2026 Filed Mar 26, 2026 12:27 UTC
Bode John BDirector
Exercise / conversionStock Option (right to buy) · Derivative 39,200 $0.00 Strike: $4.89 $0.00
Disclosure

SEC source: 0001612084-26-000002 · wk-form4_1774528025.xml · derivative · entry 4

Bode John B · CIK 0001612084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 39,200 shares

Expires 2034-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares underlying this option, which was granted on May 13, 2024, were fully vested.

Read SEC document
March 24, 2026 Filed Mar 26, 2026 12:27 UTC
Bode John BDirector
Exercise / conversionStock Option (right to buy) · Derivative 39,200 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0001612084-26-000002 · wk-form4_1774528025.xml · derivative · entry 3

Bode John B · CIK 0001612084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,600

Underlying: Common Stock · 39,200 shares

Expires 2033-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The remaining shares underlying this option, which was granted on May 3, 2023, will vest one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, subject to the Reporting Person's continued service as a director.

Read SEC document
March 24, 2026 Filed Mar 26, 2026 12:27 UTC
Bode John BDirector
Exercise / conversionCommon Stock 39,200 $4.89 $191,688.00
Disclosure

SEC source: 0001612084-26-000002 · wk-form4_1774528025.xml · nonDerivative · entry 2

Bode John B · CIK 0001612084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 24, 2026 Filed Mar 26, 2026 12:27 UTC
Bode John BDirector
Exercise / conversionCommon Stock 39,200 $4.97 $194,824.00
Disclosure

SEC source: 0001612084-26-000002 · wk-form4_1774528025.xml · nonDerivative · entry 1

Bode John B · CIK 0001612084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 18, 2026 Filed Mar 19, 2026 16:15 UTC GrantStock Option (right to buy) · Derivative 300,000 $0.00 Strike: $9.55 $0.00
Disclosure

SEC source: 0001466562-26-000007 · wk-form4_1773951351.xml · derivative · entry 1

Renz Justin A · CIK 0001466562 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2036-03-17

F1 · derivative.exercise_price: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, March 18, 2026.

F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2023 Employment Inducement Award Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become exercisable immediately prior to a change of control of the Issuer. Vesting of the option will be accelerated by 12 months if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Read SEC document
February 09, 2026 Filed Feb 10, 2026 21:49 UTC
McFarlane Neil F.Director · President and CEO
SaleCommon Stock 14,625 $8.56 $125,185.61
Disclosure

SEC source: 0001681098-26-000004 · wk-form4_1770760165.xml · nonDerivative · entry 2

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 387,225

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 3/21/2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.39 to $8.67. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 07, 2026 Filed Feb 10, 2026 21:49 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 37,500 $0.00 $0.00
Disclosure

SEC source: 0001681098-26-000004 · wk-form4_1770760165.xml · derivative · entry 3

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 37,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: One third of the restricted stock units vested and settled on February 7, 2026. The remaining two thirds of the shares will vest and settle in two equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F4 · derivative.expiration_date: One third of the restricted stock units vested and settled on February 7, 2026. The remaining two thirds of the shares will vest and settle in two equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
February 07, 2026 Filed Feb 10, 2026 21:49 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionCommon Stock 37,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001681098-26-000004 · wk-form4_1770760165.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 401,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 03, 2026 Filed Feb 4, 2026 21:27 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
SaleCommon Stock 3,000 $9.18 $27,548.10
Disclosure

SEC source: 0001698328-26-000004 · wk-form4_1770240439.xml · nonDerivative · entry 1

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,590

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 3/28/2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $8.93 to $9.52. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 03, 2026 Filed Feb 4, 2026 21:27 UTC SaleCommon Stock 10,500 $9.19 $96,500.25
Disclosure

SEC source: 0001945557-26-000004 · wk-form4_1770240428.xml · nonDerivative · entry 1

Schafer Joshua · CIK 0001945557 · CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,278

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 3/27/2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $8.92 to $9.55. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 02, 2026 Filed Feb 2, 2026 22:18 UTC
McFarlane Neil F.Director · President and CEO
SaleCommon Stock 91,000 $9.38 $853,425.30
Disclosure

SEC source: 0001681098-26-000002 · wk-form4_1770070730.xml · nonDerivative · entry 2

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 364,350

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 03-21-2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.94 to $9.53. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 31, 2026 Filed Feb 2, 2026 22:19 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
Exercise / conversionRestricted Stock Unit · Derivative 11,666 $0.00 $0.00
Disclosure

SEC source: 0001698328-26-000002 · wk-form4_1770070795.xml · derivative · entry 5

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,668

Underlying: Common Stock · 11,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date.

F5 · derivative.expiration_date: One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date.

Read SEC document
January 31, 2026 Filed Feb 2, 2026 22:19 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
Exercise / conversionCommon Stock 11,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001698328-26-000002 · wk-form4_1770070795.xml · nonDerivative · entry 3

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,590

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 31, 2026 Filed Feb 2, 2026 22:19 UTC Exercise / conversionRestricted Stock Unit · Derivative 35,334 $0.00 $0.00
Disclosure

SEC source: 0001945557-26-000002 · wk-form4_1770070744.xml · derivative · entry 7

Schafer Joshua · CIK 0001945557 · CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,333

Underlying: Common Stock · 35,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F7 · derivative.exercise_date: One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date.

F7 · derivative.expiration_date: One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date.

Read SEC document
January 31, 2026 Filed Feb 2, 2026 22:19 UTC Exercise / conversionCommon Stock 35,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001945557-26-000002 · wk-form4_1770070744.xml · nonDerivative · entry 3

Schafer Joshua · CIK 0001945557 · CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,778

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 31, 2026 Filed Feb 2, 2026 22:18 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionRestricted Stock Unit · Derivative 233,334 $0.00 $0.00
Disclosure

SEC source: 0001681098-26-000002 · wk-form4_1770070730.xml · derivative · entry 5

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 233,333

Underlying: Common Stock · 233,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date.

F6 · derivative.expiration_date: One third of the restricted stock units vested and settled on each of January 31, 2025 and January 31, 2026. The remaining one third of the shares will vest and settle on January 31, 2027, subject to the Reporting person's continued service through such vesting date.

Read SEC document
January 31, 2026 Filed Feb 2, 2026 22:18 UTC
McFarlane Neil F.Director · President and CEO
Exercise / conversionCommon Stock 233,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001681098-26-000002 · wk-form4_1770070730.xml · nonDerivative · entry 1

McFarlane Neil F. · CIK 0001681098 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 455,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
Exercise / conversionRestricted Stock Unit · Derivative 6,333 $0.00 $0.00
Disclosure

SEC source: 0001698328-26-000002 · wk-form4_1770070795.xml · derivative · entry 4

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,667

Underlying: Common Stock · 6,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F4 · derivative.expiration_date: One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
SaleCommon Stock 1,750 $8.82 $15,442.00
Disclosure

SEC source: 0001698328-26-000002 · wk-form4_1770070795.xml · nonDerivative · entry 2

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,924

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 3/28/2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.62 to $8.995. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC
Sangiovanni Timothy J.SVP, Finance & Corp Controller
Exercise / conversionCommon Stock 6,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001698328-26-000002 · wk-form4_1770070795.xml · nonDerivative · entry 1

Sangiovanni Timothy J. · CIK 0001698328 · SVP, Finance & Corp Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,674

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
Exercise / conversionRestricted Stock Unit · Derivative 11,333 $0.00 $0.00
Disclosure

SEC source: 0001788524-26-000002 · wk-form4_1770070782.xml · derivative · entry 5

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,667

Underlying: Common Stock · 11,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

F6 · derivative.expiration_date: One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
SaleCommon Stock 4,080 $8.83 $36,009.67
Disclosure

SEC source: 0001788524-26-000002 · wk-form4_1770070782.xml · nonDerivative · entry 2

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,919

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 3/27/2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.58 to $9.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
Exercise / conversionCommon Stock 11,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001788524-26-000002 · wk-form4_1770070782.xml · nonDerivative · entry 1

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,999

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC
Quartel Adrian WChief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 11,333 $0.00 $0.00
Disclosure

SEC source: 0001910132-26-000002 · wk-form4_1770070750.xml · derivative · entry 5

Quartel Adrian W · CIK 0001910132 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,667

Underlying: Common Stock · 11,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

F6 · derivative.expiration_date: One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC
Quartel Adrian WChief Medical Officer
SaleCommon Stock 4,533 $8.83 $40,035.91
Disclosure

SEC source: 0001910132-26-000002 · wk-form4_1770070750.xml · nonDerivative · entry 2

Quartel Adrian W · CIK 0001910132 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,723

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 3/26/2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.62 to $9.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC
Quartel Adrian WChief Medical Officer
Exercise / conversionCommon Stock 11,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001910132-26-000002 · wk-form4_1770070750.xml · nonDerivative · entry 1

Quartel Adrian W · CIK 0001910132 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,256

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC Exercise / conversionRestricted Stock Unit · Derivative 11,333 $0.00 $0.00
Disclosure

SEC source: 0001945557-26-000002 · wk-form4_1770070744.xml · derivative · entry 6

Schafer Joshua · CIK 0001945557 · CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,667

Underlying: Common Stock · 11,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6 · derivative.exercise_date: One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

F6 · derivative.expiration_date: One third of the restricted stock units vested and settled on January 30, 2026. The remaining two thirds of the shares will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC SaleCommon Stock 3,375 $8.83 $29,800.24
Disclosure

SEC source: 0001945557-26-000002 · wk-form4_1770070744.xml · nonDerivative · entry 2

Schafer Joshua · CIK 0001945557 · CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,444

F2 · kind: Adoption date of referenced 10b5-1(c) plan is: 3/27/2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $8.64 to $9.03. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 30, 2026 Filed Feb 2, 2026 22:19 UTC Exercise / conversionCommon Stock 11,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001945557-26-000002 · wk-form4_1770070744.xml · nonDerivative · entry 1

Schafer Joshua · CIK 0001945557 · CCO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 22:19 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
GrantStock Option (right to buy) · Derivative 75,000 $0.00 Strike: $8.86 $0.00
Disclosure

SEC source: 0001788524-26-000002 · wk-form4_1770070782.xml · derivative · entry 4

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2036-01-28

F5 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
January 29, 2026 Filed Feb 2, 2026 22:19 UTC
Thompson RahsaanChief Legal & Compliance · Secretary
GrantRestricted Stock Unit · Derivative 37,500 $0.00 $0.00
Disclosure

SEC source: 0001788524-26-000002 · wk-form4_1770070782.xml · derivative · entry 3

Thompson Rahsaan · CIK 0001788524 · Chief Legal & Compliance · Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

F4 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.